Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
acute myeloid leukemia (AML)
Pharma
For 2nd time in three months, Syndax wins FDA nod for a new drug
Syndax has gained an FDA new drug approval for the 2nd time in three months, scoring with Revuforj to treat patients with a genetic form of leukemia.
Kevin Dunleavy
Nov 18, 2024 11:09am
Daiichi Sankyo, Astellas, Takeda—Fierce Pharma Asia
Jul 28, 2023 7:56am
Daiichi scores FDA nod for leukemia med Vanflyta
Jul 21, 2023 10:05am
In expansion bid, Astellas' Xospata comes up short again
Mar 9, 2023 10:11am
Rigel's nod for Rezlidhia sets up battle with Servier in AML
Dec 2, 2022 9:57am
Particulates have prompted yet another injectable drug recall
Mar 30, 2022 9:45am
